Privia Health Group Inc
$ 24.02
2.21%
17 Apr - close price
- Market Cap 3,017,512,000 USD
- Current Price $ 24.02
- High / Low $ 24.34 / 22.52
- Stock P/E 133.44
- Book Value 5.96
- EPS 0.18
- Next Earning Report 2026-05-07
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.02 %
- ROE 0.04 %
- 52 Week High 26.51
- 52 Week Low 18.77
About
Privia Health Group, Inc. is a population health technology and medical practice management company in the United States.
Analyst Target Price
$31.80
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-26 | 2025-11-06 | 2025-08-07 | 2025-05-07 | 2025-02-25 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-02-27 | 2023-11-03 | 2023-08-03 | 2023-05-04 |
| Reported EPS | 0.25 | 0.29 | 0.02 | 0.22 | 0.21 | 0.03 | 0.03 | 0.02 | 0.02 | 0.05 | 0.06 | 0.06 |
| Estimated EPS | 0.04 | 0.05 | 0.05 | 0.1818 | 0.2008 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.06 | 0.02 |
| Surprise | 0.21 | 0.24 | -0.03 | 0.0382 | 0.0092 | -0.02 | -0.02 | -0.03 | -0.02 | 0 | 0 | 0.04 |
| Surprise Percentage | 525% | 480% | -60% | 21.0121% | 4.5817% | -40% | -40% | -60% | -50% | 0% | 0% | 200% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-07 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.08 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PRVA
2026-04-16 13:39:39
Tudor Investment Corp ET AL has significantly reduced its stake in Privia Health Group (NASDAQ:PRVA) by 95.1% in the third quarter, selling 445,865 shares and retaining only 22,986 shares valued at $572,000. This move by the prominent hedge fund signals a potential shift in investor sentiment regarding the healthcare technology company's financial infrastructure and growth prospects. Despite this reduction, Privia Health Group, which partners with independent physicians, continues its work in managing population health and optimizing financial performance.
2026-04-16 12:39:39
Tudor Investment Corp ET AL significantly reduced its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 95.1% in Q3, selling 445,865 shares and retaining 22,986 shares. Concurrently, company insiders, including CEO Parth Mehrotra, sold a substantial amount of stock. Despite these insider sales, Privia Health Group recently surpassed quarterly earnings and revenue estimates and holds a "Moderate Buy" consensus rating from analysts with an average target price of $31.31.
2026-04-12 02:40:15
This article analyzes Privia Health Group Inc. (NASDAQ: PRVA) through AI models, highlighting strong near- and mid-term sentiment and a mid-channel oscillation pattern. It presents three institutional trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss levels. The analysis also provides multi-timeframe signal strengths, support, and resistance levels for PRVA.
2026-04-11 09:10:34
Privia Health Group, Inc. (Nasdaq: PRVA) announced that it will release its first-quarter 2026 financial results before market open on Thursday, May 7, 2026. A conference call will follow at 8:00 am ET on the same day to discuss the results and future financial and operational performance. Privia Health is a significant physician enablement company in the U.S., focusing on optimizing physician practices and improving patient experience across 24 states.
2026-04-10 06:38:58
Privia Health (PRVA) has been identified as one of the top mid-cap growth stocks, with J.P. Morgan and Truist Financial increasing their price targets based on strong financial performance and management discussions. The company operates as a physician-enablement firm, offering tech-enabled health tools and value-based care. Despite its potential, the article suggests exploring AI stocks for potentially greater upside and less risk.
2026-04-09 14:40:13
Privia Health Group Inc. (NASDAQ: PRVA) is highlighted as one of the top mid-cap growth stocks. JPMorgan and Truist Financial have both increased their price targets for PRVA following strong financial results and management discussions, maintaining Overweight and Buy ratings, respectively. The company, a physician-enablement firm, uses tech-enabled tools to streamline healthcare workflows and enhance value-based care, despite some recent collection challenges related to its fee-for-service model.
